The Pharmaceutical Journal
Vol 268 No 7203 p869
22 June 2002

This article
Reprint
Photocopy

Announcements

• Relifex transfer

Announcements

Relifex transfer

Meda Pharmaceuticals will take responsibility for Relifex (nabumetone) tablets and suspension with effect from 1 July. GlaxoSmithKline will cease taking orders from 25 June, after which orders should be placed with UniDrug Distribution Group on 01773 510123.